Last updated: 11/07/2018 01:08:10
A double blind, randomized, placebo controlled trial to assess the efficacy of mupirocin in eradicating the nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and/or Moraxella catarrhalis.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A double blind, randomized, placebo controlled trial to assess the efficacy of mupirocin in eradicating the nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and/or Moraxella catarrhalis.
Trial description: A double blind, randomized, placebo controlled trial to assess the efficacy of mupirocin in eradicating the nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and/or Moraxella catarrhalis.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Winther B, Hayden FH, James C, Dalessandro M, Finlay J, Mills, D and French P. 2000 Nasopharyngeal colonization rates of H. influenzae, S. pneumoniae, and Moraxella catarrhalis in patients with early signs and symptoms of a upper respiratory infection. IDSA. New Orleans, LA: 07 – 10 SEP 00 (abstract).
Medical condition
Hypertension
Product
carvedilol
Collaborators
Not applicable
Study date(s)
January 1991 to August 1992
Type
Not applicable
Phase
2
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1992-26-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website